These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 9006809

  • 21. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
    de Man FH, de Beer F, van der Laarse A, Jansen H, Leuven JA, Souverijn JH, Vroom TF, Schoormans SC, Fruchart JC, Havekes LM, Smelt AH.
    Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425
    [Abstract] [Full Text] [Related]

  • 22. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [Abstract] [Full Text] [Related]

  • 23. Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins.
    Zimetbaum P, Frishman WH, Kahn S.
    J Clin Pharmacol; 1991 Jan; 31(1):25-37. PubMed ID: 2045526
    [Abstract] [Full Text] [Related]

  • 24. Effects of fibric acid derivatives and metformin on postprandial lipemia.
    Weintraub MS, Charach G, Grosskopf I.
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S71-5. PubMed ID: 9888646
    [Abstract] [Full Text] [Related]

  • 25. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 26. Fibric acids: effects on lipids and lipoprotein metabolism.
    Grundy SM, Vega GL.
    Am J Med; 1987 Nov 27; 83(5B):9-20. PubMed ID: 3318457
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
    Totsuka M, Miyashita Y, Ito Y, Watanabe H, Murano T, Shirai K.
    Atherosclerosis; 2000 Nov 27; 153(1):175-9. PubMed ID: 11058713
    [Abstract] [Full Text] [Related]

  • 28. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
    Farnier M, Salko T, Isaacsohn JL, Troendle AJ, Dejager S, Gonasun L.
    Am J Cardiol; 2003 Oct 01; 92(7):794-7. PubMed ID: 14516878
    [Abstract] [Full Text] [Related]

  • 29. Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.
    Ginsberg HN, Ngai C, Wang XJ, Ramakrishnan R.
    Arterioscler Thromb; 1993 Jun 01; 13(6):842-51. PubMed ID: 8499404
    [Abstract] [Full Text] [Related]

  • 30. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
    Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D.
    Atherosclerosis; 1997 Mar 21; 129(2):231-9. PubMed ID: 9105566
    [Abstract] [Full Text] [Related]

  • 31. Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.
    Chan MK.
    Metabolism; 1989 Oct 21; 38(10):939-45. PubMed ID: 2507877
    [Abstract] [Full Text] [Related]

  • 32. Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect Of bezafibrate treatment.
    Attia N, Durlach V, Cambilleau M, Roche D, Girard-Globa A.
    Atherosclerosis; 2000 Apr 21; 149(2):427-33. PubMed ID: 10729394
    [Abstract] [Full Text] [Related]

  • 33. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028
    [Abstract] [Full Text] [Related]

  • 34. Production of small high-density lipoprotein particles after stimulation of in vivo lipolysis in hypertriglyceridemic individuals: studies before and after triglyceride-lowering therapy.
    Lewis GF, Uffelman KD, Lamarche B, Cabana VG, Getz GS.
    Metabolism; 1998 Feb 24; 47(2):234-42. PubMed ID: 9472977
    [Abstract] [Full Text] [Related]

  • 35. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
    Hsu HC, Lee YT, Yeh HT, Chen MF.
    J Lab Clin Med; 2001 Jun 24; 137(6):414-21. PubMed ID: 11385362
    [Abstract] [Full Text] [Related]

  • 36. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
    Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN.
    J Clin Lipidol; 2012 Jun 24; 6(6):565-72. PubMed ID: 23312052
    [Abstract] [Full Text] [Related]

  • 37. No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased.
    Neele DM, Kaptein A, Huisman H, de Wit EC, Princen HM.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):374-8. PubMed ID: 9514936
    [Abstract] [Full Text] [Related]

  • 38. Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
    Saito Y, Yamada N, Shirai K, Sasaki J, Ebihara Y, Yanase T, Fox JC.
    Atherosclerosis; 2007 Oct 17; 194(2):505-11. PubMed ID: 17223112
    [Abstract] [Full Text] [Related]

  • 39. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ, Pei D, Wu DA, Kuo SW, Fuh MM, Jeng C.
    J Formos Med Assoc; 1999 Feb 17; 98(2):104-10. PubMed ID: 10083765
    [Abstract] [Full Text] [Related]

  • 40. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA, O'Connell DP, Lamon-Fava S, LeBlanc DF, Kuang YL, Schaefer EJ, Coppage AL, Benedict CR, Kiritsy CP, Bachovchin WW.
    Metabolism; 2013 Dec 17; 62(12):1840-9. PubMed ID: 24035454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.